Tranylcypromine

How Does Tranylcypromine Work?

Tranylcypromine is a nonselective, irreversible monoamine oxidase inhibitor. It permanently blocks the MAO-A and MAO-B enzymes that normally break down the mood-regulating neurotransmitters serotonin, dopamine, and norepinephrine. By preventing their breakdown, tranylcypromine increases the availability of all three monoamines in the brain simultaneously — a broader mechanism than SSRIs (serotonin only) or SNRIs (serotonin and norepinephrine).

Because the inhibition is irreversible, MAO enzymes cannot simply be reactivated — the body must synthesize new enzymes over approximately 10 days after stopping the drug. This is why dietary tyramine restrictions and drug interaction precautions continue for at least 2 weeks after the last dose. Tranylcypromine may also act as a norepinephrine reuptake inhibitor at higher therapeutic doses, contributing to its relatively activating profile.

The broader monoamine mechanism explains why tranylcypromine can be effective in patients who have failed SSRIs, SNRIs, and other antidepressant classes — it works through a fundamentally different pathway that simultaneously targets all three major mood-regulating neurotransmitter systems.

How Hard Is It to Find Tranylcypromine in Stock?

Tranylcypromine is not on the FDA's active shortage list in 2026, but patients consistently report difficulty finding it at local chain pharmacies. As a low-volume specialty medication prescribed to a relatively small patient population, most retail pharmacies — CVS, Walgreens, Rite Aid, Walmart — do not maintain standing inventory. They may have it available through a special order, but it's not reliably on the shelf.

Hospital outpatient pharmacies and independent community pharmacies tend to be the most reliable sources. Mail-order pharmacy through insurance is the best long-term option for stable patients. Patients are advised to start their refill search at least 7–10 days before running out and to ask pharmacies about special ordering.

The fastest way to find tranylcypromine in stock is to use medfinder: enter your medication and zip code, and medfinder calls pharmacies near you to check stock, then texts you the results.

Who Can Prescribe Tranylcypromine?

Tranylcypromine is not a controlled substance and can be prescribed by any licensed prescriber with DEA prescribing authority. However, due to its complex safety profile — requiring extensive dietary counseling, drug interaction screening, cardiovascular assessment, and ongoing monitoring — it is almost exclusively initiated by psychiatric specialists in practice.

Prescriber types who typically manage tranylcypromine:

Psychiatrists — Primary prescribers; especially psychopharmacologists or specialists in treatment-resistant depression

Primary care physicians (PCPs) — May continue a prescription initiated by a psychiatrist; rarely initiate MAOI therapy independently

Psychiatric nurse practitioners (PMHNPs) — Board-certified psychiatric NPs can prescribe in most states; experience with MAOIs varies

Physician assistants (PAs) in psychiatry — PAs with psychiatric specialty training can prescribe with appropriate supervision

Telehealth prescribing is technically permissible (no controlled substance requirements), but most telehealth platforms do not initiate MAOI therapy for new patients due to the complexity of in-person monitoring requirements. Continuation of an existing tranylcypromine prescription via established telehealth relationship is generally feasible.

Is Tranylcypromine a Controlled Substance?

No. Tranylcypromine is not a federally scheduled controlled substance (DEA Schedule I–V). Any licensed prescriber with prescribing authority can write for it without the special restrictions that apply to controlled substances like stimulants, benzodiazepines, or opioids.

However, tranylcypromine is available by prescription only — it cannot be purchased over the counter. Because of its complex safety profile (dietary restrictions, extensive drug interactions, boxed warnings for hypertensive crisis and suicidality), it is effectively managed as a specialty psychiatric medication and is almost always prescribed by psychiatrists rather than general practitioners.

There are no controlled substance-specific refill restrictions (e.g., no limit to 30-day fills by law), though insurance plans may impose their own quantity limits. Telemedicine prescribing is technically permitted since no DEA special registration is required, though in practice most telehealth platforms do not initiate MAOI therapy.

Common Side Effects of Tranylcypromine

The most common side effects include:

Insomnia (most frequent; manage by taking last dose before 3 PM)

Dizziness and orthostatic hypotension (especially at doses above 30 mg/day)

Dry mouth

Headache

Sedation or restlessness/agitation

Palpitations and tachycardia

Serious side effects requiring immediate medical attention:

Hypertensive crisis — sudden severe headache, neck stiffness, chest pain, sweating, nausea; call 911 immediately

Serotonin syndrome — agitation, high fever, muscle twitching, confusion, rapid heart rate; life-threatening emergency

Suicidal ideation — boxed warning for increased suicidality in pediatric and young adult populations; monitor closely

Mania or hypomania — risk increased in patients with undiagnosed bipolar disorder

Withdrawal symptoms — on abrupt discontinuation: restlessness, confusion, hallucinations, diarrhea

Final Thoughts on Tranylcypromine

Tranylcypromine is a powerful tool in the psychiatric pharmacopeia for a population that genuinely needs it — patients with treatment-resistant depression who have not found relief from other antidepressants. For the right patient, it can be transformative. The medication requires careful management, a committed prescriber, and patient education about dietary restrictions and drug interactions, but its clinical efficacy in resistant cases is well-established.

Pharmacy access is the most practical ongoing challenge for tranylcypromine patients. The medication is not on an active shortage list, but low prescription volume means it's not routinely stocked at most chain pharmacies. The most reliable strategies are identifying a hospital outpatient or independent pharmacy that stocks it, using mail-order pharmacy for 90-day supplies, and starting refill searches well before running out.

When you need help locating tranylcypromine at a nearby pharmacy, medfinder calls pharmacies near you and texts you which ones have it in stock — saving you the time and frustration of calling pharmacies yourself.